Home Data License About Get in touch

THE EXCLUSIVE PATIENT DATA LAYER

For pharma brands, agencies, holding companies, DSPs, and identity platforms building on consented patient intent.

The Asset

15.3 million people who already raised their hand.

They saw an unbranded condition ad, clicked through, and asked for information. Self-identified at intake, consented at the point of capture, and exclusively licensed through 2046. The action a brand's media budget is built to produce — Summit already has 15.3 million of them.

Talk to our team ↗ See license structures ↗
Condition‑Confirmed Inquiries
0
Operationally generated, self-identified
Condition Pathways
9
Diabetes · OSA · Cardiac · GLP-1 · More
Exclusive License
20‑Year
2026–2046 · No competitor access
License Window
2026–2046
Two-decade exclusivity window
Cohort Refresh
Monthly
Continuous ingestion from live campaigns
Compliance Posture
HIPAA‑Safe‑Harbor
De-identified · BAA flow-down available

The Data · The Cheat Code

A decade of intake.
Already run. Yours on day one.

What it takes to build this from scratch
10+ years of unbranded campaign operations across 9 condition pathways
Three operating entities running condition-specific patient acquisition in parallel
Hundreds of millions in media spend, intake infrastructure, and call-center capacity
A decade of intake forms, consent capture, and fulfillment partnerships that can't be reverse-engineered
10+ Years · 9 Conditions · Three Entities
What you get on Day One with a Summit license
15.3M+ condition-confirmed inquiries — every record traces to a self-identified patient
20-year exclusive license to a dataset no competitor can access
First-party, consent-based, HIPAA Safe Harbor de-identified — already compliant
Monthly cohort refresh with stable counts per activation window
Day One · 20-Year Exclusive · Monthly Refresh
Built once. Licensed for two decades.  ·  Replication cost: hundreds of millions  ·  Acquisition cost: a license fee.

What's Inside Each Record

Depth, not just size.

The 15.3M record count is the headline. What makes each record exclusive is the action behind it — and the layers that prove the audience converts when you activate it.

9 Condition Pathways
9
Diabetes, Obstructive Sleep Apnea, Cardiac, Obesity / GLP-1, Polypharmacy, Medicare Advantage, Chronic Pain, Incontinence, Respiratory
100% First-Party
✓
Every record originated from an unbranded campaign Summit operated. No purchased lists, no third-party append, no modeled lookalikes.
100% Consent-Based
✓
Scope, duration, and opt-out tracked per record at the moment of intake.
Cohort Refresh
Monthly
Continuous ingestion against ongoing campaign operations. Stable counts per activation window.

Downstream proof tiers (available within any license structure):

218,071 T2 Dx-qualified patients 140,216 T1 Tx-verified patients 166,464 prescriber NPIs 386,000+ cross-tier phone matches

How Brands Use It

What Summit unlocks.
Five use cases T3 unlocks directly. Three more when you layer in the proof tiers.

Primary — T3-driven
01
New Patient Acquisition
Reach diagnosed patients already in-market. Verified condition + intent signal at the moment they raised their hand on an unbranded campaign.
TIER MIX: T3 + CTC
02
Coverage — Medicare Expansion
Activate patients whose newly opened coverage just unlocked access to previously unaffordable therapy.
TIER: T3 + Medicare segment
03
Access — Access Program Targeting
The 218,071 T2 cohort: clinically qualified, blocked on insurance authorization or documentation. The exact audience access programs are built for.
TIER: T2
04
Modeling — Seed Audiences for Lookalike Expansion
Real condition-confirmed intent as the seed. Not behavioral proxies, not claims-data inference. The seed defines the expansion.
TIER: T3 seed
05
AI — Predictive Model Training
Verified, consented, condition-confirmed records as positive-label training input. Downstream Rx fulfillment outcomes available for validation.
TIER: T3 + T1 validation
Secondary — Proof tiers
06
Adherence — Refill & Persistence
Multi-year supply behavior with patient-level fill cadence on file. Activate at predicted refill or abandonment moments.
TIER: T1 + GLP-1
07
Switching — Brand Conversion
Patients on competitor therapies who match the switch profile. Comorbidity-aware, payer-aware.
TIER: T1 + cross-brand overlay
08
HCP — Prescriber Activation
166,464 prescriber NPIs linked to confirmed patient volume. Warm prescribers attached to real panels — not cold specialty codes.
TIER: HCP Layer + condition

One dataset. Eight use cases. Brand picks the outcome; Summit configures the tier mix.

Starting the Conversation

Where this goes next depends
on what you're building.

Summit licenses to brands, agencies, holding companies, DSPs, and strategic partners across four structures. The right one depends on what you're protecting — a single campaign, a category, the data itself, or a distribution channel.

Brands
Scope a license against your target condition.
Cohort sizing and structure recommendation back within a week.
Agencies + holding companies
Multi-brand access across the data layer.
Available under non-exclusive and category-exclusive structures.
DSPs + data platforms + identity vendors
Distribution and partnership structures.
Summit retains data ownership; partner owns the activation surface and the client relationship.
Talk to our team ↗ See license structures ↗

info@summitaudiencesegments.com